Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trader J's Inner Circle -- Ignore unavailable to you. Want to Upgrade?

To: Canuck Dave who wrote (34993)	9/25/2000 9:48:29 AM
From: Softechie	Read Replies (1) \| Respond to of 56532

Canuck, Have you seen what's going on over Randy's thread? They're voting on my first admenment...hahaha what a joke! To see both sides of the coin is making you much better of an investor and they seem don't know that. They want to hear good news only. For someone resorted to do such a thing is what I call "paranoid and control freak" (no disrespect for people over there though). Speculative trade: FNV. If you have strong stomach to ride. They're working overtime in negotiating with buyer(s) or get more funding for their debts in 2001. They have a strong loans portfolio but they're asking too high for a buyout price. I think they'll settle for mid teens.

To: Canuck Dave who wrote (34993)	10/1/2000 11:19:23 PM
From: J.S.	Read Replies (1) \| Respond to of 56532

Are you still following AVN? The Abreva cold store cream is ready to hit the markets and so is the ad campaign by SmithKline Beecham. I think that because the cream can also be applied to genital cases, that this will mean even additional media exposure. Being on the AMEX and just coming out of OTCBB obscurity and other turmoil, I think this stock could become discovered in a big way. I am trading it but am principally keeping a long term core position.